Returning to the workplace during COVID-19: RSK supports CDC’s international guidance note

July 07, 2020

Governments around the world are starting to ease lockdown measures introduced to limit the spread of COVID-19 and companies must now transition to a new way of doing business to ensure safety in the workplace. To help businesses return to work safely, RSK has developed a COVID-19 guidance note for CDC Group (part of The Department for International Development (DFID)), a development finance institution owned by the UK government that supports business growth in Africa and South Asia.

CDC Group has produced two guidance notes to help companies that are preparing to return to work to address labour-related challenges and offer guidance on the best approach to ensure occupational health and safety. CDC Group explains: “The gradual relaxation of lockdown measures enforced due to the COVID-19 pandemic does not signal a return to ‘business as usual’ for most companies. Instead, they mark a transition to a new way of doing business by confronting a set of previously unencountered challenges. This includes the pressing need to ensure that workers (and customers) are safe in newly re-opened workplaces, and to make further preparations to respond to difficult economic conditions and ongoing uncertainty about the trajectory and consequences of the COVID-19 outbreak. To address this, we have produced two separate, but related, guidance notes to help companies preparing to return to work.”

The first, ‘Returning to the workplace during COVID-19: Occupational health and safety considerations’, was developed in association with RSK’s COVID-19 Safety and Risk team. It provides general and sector-specific guidance on COVID-19 hazards and controls and information and advice to employers, employees and others potentially affected by COVID-19, and who may need to implement additional health and safety controls in their workplace. It should be read alongside CDC Group’s ‘Returning to the workplace during COVID-19: Labour and workforce consideration’ guidance note, developed in association with Ergon.

The guidance note will now be explored at an upcoming webinar, ‘Labour and occupational health and safety aspects when returning to work’ that RSK will host with CDC Group and Ergon on 6 July.

You can read the guidance note in full, ‘Returning to the workplace during COVID-19: Occupational health and safety considerations’, on the CDC Group website.

For more information on RSK’s COVID-19 safety and risk services, please contact

Martin Geer

Associate Director

RSK Group

07880 203919

mgeer@rsk.co.uk